Resverlogix Corp. has experienced mixed performance recently, with a notable price increase today.
Resverlogix Corp. (RVX.TO) saw its stock rise by 5.88% in today's trading, closing at C$0.09. The company has been navigating recent regulatory challenges, including the revocation of a management cease trade order (MCTO) by the Alberta Securities Commission. This development, along with updates surrounding their financial filings, has positioned the company in the spotlight for investors following the health care sector closely.
Advertisement
Resverlogix Corp.
RVX.TO
RVX.TO
Resverlogix Corp.
WealthAwesomeMarket cap
$30.99M
52W high
$0.15
52W low
$0.09
1W change
+0.00%
Beta
1.05
Analyst Price Targets
Based on analyst covering RVX · as of Sep 17, 2026
Wall Street analysts forecast RVX stock price to rise 8455.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.70
+8455.6% Upside
Current Price
C$0.09
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on RVX's historical volatility
30-Day Vol
63.9%
Annualized
90-Day Vol
72.0%
Annualized
Trend (90d)
-22.7%
Annualized drift
90d Mean
C$0.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.09 | C$0.07 – C$0.11 |
| 60 trading days | C$0.09 | C$0.06 – C$0.12 |
| 90 trading days | C$0.08 | C$0.06 – C$0.12 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should remain cautious as Resverlogix continues to face challenges in financial reporting while also showing potential with its therapeutic developments. The stock's recent upward movement may reflect a positive sentiment around its regulatory progress and ongoing clinical research.
Resverlogix Corp. Stock Rises 5.88% Today, Still Down 10% YTD
With a current market cap of approximately C$30.99 million, Resverlogix's stock is trading at the lower end of its 52-week range, suggesting potential volatility and investor caution.
Bull case
The recent revocation of the MCTO signals a potential stabilization in Resverlogix's governance and operations, which could enhance investor confidence. The publication of scientific articles related to their lead candidate, apabetalone, may also attract interest from stakeholders in the health care sector.
Bear case
Despite today's gains, Resverlogix's stock remains down 10% year-to-date, and the company has a history of financial reporting delays. Investors should be aware of the risks associated with investing in companies that are still navigating regulatory hurdles and have yet to demonstrate consistent profitability.
Recent Price Action
Advertisement
Resverlogix Corp. (RVX.TO) closed at C$0.09, marking a 5.88% increase in today's trading session. The stock has remained flat over the past week, with a modest decline of 5.26% over the last month. Year-to-date, the stock is down 10%, reflecting the challenges the company has faced in its financial reporting and operations.
Company News and Headlines
The most recent news surrounding Resverlogix includes the announcement of the revocation of a management cease trade order (MCTO) by the Alberta Securities Commission. This development, along with updates related to their annual financial filings, indicates progress in the company's governance. Furthermore, the publication of scientific articles regarding their lead candidate, apabetalone, suggests ongoing research and development efforts that could be pivotal for future growth.
Technical Picture
From a technical standpoint, Resverlogix is currently trading below its 50-day and 200-day moving averages, both at C$0.10. The stock has a 52-week range of C$0.09 to C$0.15, indicating it is trading at approximately 8% of its range. With a beta of 1.05, the stock exhibits slightly higher volatility compared to the overall market. The recent trading volume of 35,685 shares is notably above the 20-day average volume of 23,448 shares, pointing to increased investor interest.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
